UBS AM’s BioNTech BNTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $27.3M | Buy |
256,874
+38,452
| +18% | +$4.09M | 0.01% | 923 |
|
|
2025
Q1 | $19.9M | Sell |
218,422
-2,658
| -1% | -$242K | 0.01% | 969 |
|
|
2024
Q4 | $25.2M | Buy |
221,080
+36,746
| +20% | +$4.19M | 0.01% | 863 |
|
|
2024
Q3 | $21.9M | Sell |
184,334
-47,213
| -20% | -$5.61M | 0.01% | 908 |
|
|
2024
Q2 | $18.6M | Buy |
231,547
+17,558
| +8% | +$1.41M | 0.01% | 889 |
|
|
2024
Q1 | $19.7M | Sell |
213,989
-781,264
| -78% | -$72.1M | 0.01% | 796 |
|
|
2023
Q4 | $105M | Buy |
995,253
+137,115
| +16% | +$14.5M | 0.04% | 421 |
|
|
2023
Q3 | $93.2M | Buy |
858,138
+397,315
| +86% | +$43.2M | 0.04% | 417 |
|
|
2023
Q2 | $57.4M | Hold |
460,823
| – | – | 0.03% | 523 |
|
|
2023
Q1 | $57.4M | Sell |
460,823
-19,478
| -4% | -$2.43M | 0.03% | 523 |
|
|
2022
Q4 | $72.2M | Buy |
480,301
+140,865
| +41% | +$21.2M | 0.04% | 461 |
|
|
2022
Q3 | $45.8M | Buy |
339,436
+134,663
| +66% | +$18.2M | 0.03% | 574 |
|
|
2022
Q2 | $30.5M | Buy |
204,773
+24,700
| +14% | +$3.68M | 0.02% | 648 |
|
|
2022
Q1 | $30.7M | Buy |
180,073
+28,446
| +19% | +$4.85M | 0.01% | 730 |
|
|
2021
Q4 | $39.1M | Buy |
151,627
+58,400
| +63% | +$15.1M | 0.02% | 716 |
|
|
2021
Q3 | $25.5M | Sell |
93,227
-33,271
| -26% | -$9.08M | 0.01% | 810 |
|
|
2021
Q2 | $28.3M | Sell |
126,498
-201,340
| -61% | -$45.1M | 0.01% | 795 |
|
|
2021
Q1 | $35.8M | Buy |
327,838
+46,556
| +17% | +$5.08M | 0.02% | 705 |
|
|
2020
Q4 | $22.9M | Buy |
281,282
+141,090
| +101% | +$11.5M | 0.01% | 818 |
|
|
2020
Q3 | $9.71M | Sell |
140,192
-62,014
| -31% | -$4.29M | 0.01% | 950 |
|
|
2020
Q2 | $13.5M | Buy |
+202,206
| New | +$13.5M | 0.01% | 841 |
|